Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

20 déc. 2013 10h44 HE | Source: Medistem, Inc.

Intrexon to Acquire Medistem to Generate Multipotent Cells

GERMANTOWN, Md. and SAN DIEGO, Dec. 20, 2013 (GLOBE NEWSWIRE) -- Intrexon Corporation (NYSE:XON), a leader in synthetic biology, today announced that it has entered into a definitive agreement to...
14 nov. 2013 09h00 HE | Source: Medistem, Inc.

Medistem Begins Trading on the OTCQB

SAN DIEGO, Nov. 14, 2013 (GLOBE NEWSWIRE) -- Medistem Inc. (OTCQB:MEDS), today announced that its shares of common stock are now listed on the OTC Markets Group's OTCQB marketplace. The company's...
03 oct. 2013 11h50 HE | Source: Medistem, Inc.

Medistem Announces Preclinical Data on Type 1 Diabetes and Filing of Intellectual Property

SAN DIEGO, Oct. 3, 2013 (GLOBE NEWSWIRE) -- Medistem, Inc. (Pink Sheets: MEDS), announced today that it filed patent application #61/885909 covering immune modulatory aspects of ERC-124, the Company's...
25 sept. 2013 11h18 HE | Source: Medistem, Inc.

Medistem to Present at Aegis Capital 2013 Healthcare Conference

SAN DIEGO, Sept. 25, 2013 (GLOBE NEWSWIRE) -- Medistem, Inc. (Pink Sheets:MEDS), today announced that its President and CSO, Thomas Ichim, Ph.D., will present at the Aegis Capital 2013 Healthcare...